cropped-logo.png

RegenSight

We are the TECH Company

  • Company
      • About Us
      • Team
      • Resources & Opportunities
  • Science & Technology
      • Technologies
      • Projects
      • Clinical Trials
      • Visual Disorder
      • Publications and Presentations
  • Products
      • Devices for the CXL
        • C4V CHROMO4VIS
        • RitSight
      • Medical Professionals
      • Partnership
  • Granting & Investing
      • Public Granting
      • Investing
  • News & Media
  • Contacts
  • English
    • Italiano

Home

All posts by : Marco Lombardo

post_linkedin_regensight-news-2
August 4, 2023
by Marco Lombardo News

Join Regensight at ESCRS 2023 in Vienna

Visit us at our booth C405 (Hall C) on 8 - 11 September during ESCRS 2023 and meet our Team! We at Regensight are introducing Theranostics for incision-free treatment of visual disorders. You will discover the C4V CHROMO4VIS breakthrough UV-A devic ...

Leggi di più
Screenshot 2023-06-01 084144
June 1, 2023
by Marco Lombardo News

Pre-clinical validation outcomes of theranostic-guided corneal cross-linking published

In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through  ...

Leggi di più
Alletto_post
May 4, 2023
by Marco Lombardo BUSINESSNews

Regensight appoints Loredana Alletto as Chief Operating Officer

Loredana Alletto is the Chief Operating Officer of Regensight. She will lead the strategies and operations of Regensight, consistently with the objective of affirming the new paradigm of theranostics for predictive and precision treatment of keratoconu ...

Leggi di più
IMG-20230315-WA0007
April 2, 2023
by Marco Lombardo News

Regensight guest of TeamViewer at Embedded World

Elevating the standard of care to patients starts from the beginning of project development and the real understanding of eye doctors needs. We at Regensight are meeting this challenge and transforming eye doctors experience in treating keratoconus using ...

Leggi di più
ARGO protocol 1
January 4, 2023
by Marco Lombardo News

ARGO clinical trial protocol

The ARGO clinical trial protocol has been published in the “New Treatments for Keratoconus” Special Issue of International Ophthalmology. The publication is open access and available at https://link.springer.com/article/10.1007/s10792-022-02628-4. T ...

Leggi di più
JBIO_202270025_IC.indd
December 29, 2022
by Marco Lombardo News

Scientific publication on theranostic-guided corneal cross-linking on the cover of Journal of Biophotonics

Pleased to end this amazing year with the honor to see our most recent publication on theranostics on the cover of Journal of Biophotonics. The article is open access and available at https://onlinelibrary.wiley.com/doi/10.1002/jbio.202200218. Theranost ...

Leggi di più
Premio 1
December 23, 2022
by Marco Lombardo News

The Mario Lombardo Research Prize has been awarded to a young ophthalmologist

The Mario Lombardo award has been assigned to Dr. Raffaella Gioia, a young ophthalmologist recently specialized at the Magna Graecia University of Catanzaro. The celebration was held at the Regensight Research & Development Lab. in Reggio C ...

Leggi di più
Premio 2022
December 15, 2022
by Marco Lombardo News

The first “Mario Lombardo” Research Award goes to Dr. Raffaella Gioia

We are pleased to award the "Mario Lombardo" Research Prize to Dr. Raffaella Gioia, who ha been recently specialized in Ophthalmology at the Magna Graecia University of Catanzaro. We at Regensight award the commitment of Raffaella to the study and mana ...

Leggi di più
Premio
October 31, 2022
by Marco Lombardo News

Mario Lombardo Research Award

Glad to promote the Mario Lombardo Research Award. The award will be assigned to a young research devoted to  the research & development of new methods and techniques for the prevention, diagnosis and treatment of keratoconus. For more information ...

Leggi di più
cover
September 21, 2022
by Marco Lombardo News

New scientific publication showing efficacy of theranostics for the treatment of keratoconus

A new scientific research was recently published in the prestigious Journal of Biophotonics. The study shows the pre-clinical efficacy results of the innovative theranostic-guided corneal cross-linking procedure for the treatment of keratoconus. The s ...

Leggi di più
  • First
  • Previous
  • 1
  • 2
  • 3
  • Next
  • Last

Search

Recent Posts

  • Regensight is sponsor of the WorldKeratoconus Congress 2025
  • RitSight has been issued the MDR CE Certification
  • The Teracor project for the correction of visual disorders with theranostics is moving forward quickly
  • ARGO clinical study published in the prestigious scientific journal Ophthalmology
  • Regensight at ESCRS 2024

Recent Comments

    Archives

    • March 2025
    • January 2025
    • September 2024
    • July 2024
    • June 2024
    • April 2024
    • February 2024
    • November 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • January 2023
    • December 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • January 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021

    Categories

    • BUSINESS
    • News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Premio di Ricerca

    Mario Lombardo

    Ad un giovane ricercatore impegnato nello studio del cheratocono

    Scopri di più
    cropped-logo.png

    The TECH Company

    Regensight è l’azienda biomedicale che ha sviluppato la teranostica per offrire trattamenti oftalmici personalizzati e migliorare la vista e la qualità della vita a chi soffre di disturbi visivi ad ogni età.

    Info
    Regensight srl è azienda certificata ISO 13485:2021. Organismo Notificato: TÜV Rheinland Italia.

    Informativa ai sensi dell’art. 13 del Regolamento UE 2016/679

    Links Utili
    • Home
    • Products
    • Contacts
    • News & Media
    • Privacy Policy
    • Cookies Policy
    Nota

    Le informazioni del «Sito» relative a dispositivi medici non sono di natura pubblicitaria ma materiale informativo rivolto esclusivamente al personale medico. Proseguendo nella navigazione l’utente dichiara di essere un Professionista dell’area sanitaria

    Sign Up

    Keep me up to date with content, updates, and offers from Phlox

    "MailChimp" Plugin is Not Activated! In order to use this element, you need to install and activate this plugin.
    © 2025. Regensight | Creative web design by Arkomedia Web Agency
    Shopping Basket